 |
 |
|
|
|
RESÚMENES MAYO 2010 |
Tratamiento de Otros Trastornos Neuropsiquiátricos
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
4 - Early response to
antidepressant treatment
in bulimia nervosa
R. Sysko, N. Sha, Y.
Wang, N. Duan and B. T. Walsh
Psychological
Medicine (2010), 40:999-1005
5< - Effectiveness
of Standardized Ginkgo biloba Extract
on Cognitive Symptoms of Dementia
with a Six-Month Treatment: A Bivariate Random Effect Meta-Analysis
B.-S. Wang,
H. Wang,
Y.-Y. Song, H. Qi, Z.-X. Rong, B.-S. Wang,
L. Zhang, H.-Z. Chen
Pharmacopsychiatry 2010; 43(3): 86-91
3! - Ocular
Adverse Effects of Common Psychotropic Agents: A Review
Richa, Sami; Yazbek,
Jean-Claude
CNS Drugs: 1
June 2010 - Volume 24 - Issue 6 - pp 501-526
3
- Effects of
Antidepressive
Treatment of Saint John's Wort Extract Related
to Autonomic Nervous Function in Women with Irritable Bowel Syndrome
Hongyu Wan and Yulong Chen
The
International Journal of Psychiatry in Medicine. Volume 40, Number 1
/ 2010: 45 - 56
3
- A
review
comparing the safety and tolerability of memantine with the
acetylcholinesterase inhibitors
R. W. Jones
International
Journal of Geriatric Psychiatry. Volume 25 Issue
6, Pages 547 - 553
5<
- The Effect of
Ondansetron, a 5-HT3 Receptor
Antagonist, in Chronic Fatigue Syndrome: A Randomized Controlled Trial
Gerard K. H. The, Gijs
Bleijenberg, Jan K. Buitelaar, and Jos W. M. van
der Meer
J Clin
Psychiatry 2010;71(5):528–533
5
- Efficacy and Safety of
Duloxetine in Patients With
Chronic Low Back Pain
Skljarevski, Vladimir;
Desaiah, Durisala; Liu-Seifert, Hong; Zhang, Qi;
Chappell, Amy S; Detke, Michael J; Iyengar, Smriti; Atkinson, Joseph H;
Backonja, Miroslav
Spine: 1
June 2010 - Volume 35 - Issue 13 - pp E578-E585
3!
-
Finasteride Treatment Inhibits Adult Hippocampal
Neurogenesis in Male Mice
B. Römer,
N. Pfeiffer,
S. Lewicka, N. Ben-Abdallah, M. A. Vogt,
M. Deuschle,
B. Vollmayr, P. Gass
3
- Inappropriate
Prescribing Predicts Adverse Drug
Events in Older Adults
Brian C Lund, Ryan M
Carnahan, Jason A Egge, Elizabeth A Chrischilles,
Peter J Kaboli
The Annals
of Pharmacotherapy: Vol. 44,
No. 6, pp. 957-963
5
-
Pramipexole for the treatment of depressive symptoms in patients with
Parkinson's disease: a randomised, double-blind, placebo-controlled
trial
Paolo Barone, Werner
Poewe, Stefan Albrecht,
Catherine Debieuvre, Dan Massey, Olivier Rascol, Eduardo Tolosa and
Daniel
Weintraub
The Lancet
Neurology. Volume 9, Issue 6, June 2010, Pages 573-580
3
- Evaluation of Efficacy
of the Perioperative
Administration of Venlafaxine or Gabapentin on Acute and Chronic
Postmastectomy
Pain
Amr, Yasser Mohamed;
Yousef, Ayman Abd Al-Maksoud
The Clinical
Journal of Pain: June 2010 - Volume 26 - Issue 5 - pp
381-385
3
- The Role
of
the Selective Serotonin Re-Uptake Inhibitor Sertraline in Nondepressive
Patients with Chronic Ischemic Heart Failure: A Preliminary Study.
Leftheriotis D, Flevari
P, Ikonomidis I, Douzenis A, Liapis C,
Paraskevaidis I, Iliodromitis E, Lykouras L, Kremastinos DT
Pacing Clin
Electrophysiol. 2010 May 11. [Epub ahead of print]
3
- Therapeutic strategies
in migraine patients with mood
and anxiety disorders: clinical evidence
Cinzia Finocchi,
Veronica Villani and Gerardo Casucci
Neurological
Sciences. Volume 31, Supplement 1 / June, 2010: 95-98
3
- Marked Improvement of
Psychotic Symptoms After
Electroconvulsive Therapy in Parkinson Disease
Ueda,
Satoshi; Koyama, Keiko; Okubo, Yoshiro
The Journal
of ECT: June 2010 - Volume 26 - Issue 2 - pp 111-115
3!
-
Risperidone versus olanzapine for the treatment of delirium
Sung-Wan Kim, Joon-An
Yoo, Sam-Yeon Lee, Seon-Young Kim, Kyung-Yeol Bae,
Su-Jin Yang, Jae-Min Kim, Il-Seon Shin, Jin-Sang Yoon
Human
Psychopharmacology: Clinical and Experimental. Volume 25 Issue
4, Pages 298 - 302
3
- Non-specific effects of
methylphenidate (Ritalin) on
cognitive ability and decision-making of ADHD and healthy adults
Nirit Agay,
Eldad Yechiam, Ziv Carmel and
Yechiel Levkovitz
Psychopharmacology. Volume
210, Number 4 / July, 2010: 511-519
3
- Phase III,
Placebo-Controlled Trial of Three Doses of
Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9
Debra L. Barton, Beth I.
LaVasseur, Jeff A. Sloan, Allen N. Stawis,
Kathleen A. Flynn, Missy Dyar, David B. Johnson, Pamela J. Atherton,
Brent
Diekmann, Charles L. Loprinzi
Journal of
Clinical Oncology, May 2010
5
-
Efficacy
and safety of milnacipran 100 mg/day in patients with fibromyalgia:
Results of
a randomized, double-blind, placebo-controlled trial
Lesley M. Arnold, R.
Michael Gendreau, Robert H. Palmer, Judy F.
Gendreau, Yong Wang
Arthritis
& Rheumatism. Volume 9999 Issue 999A, Page NA
3!
- Are
All
Commonly Prescribed Antipsychotics Associated with Greater Mortality in
Elderly
Male Veterans with Dementia?
Rebecca
C. Rossom, Thomas
S. Rector, Frank
A. Lederle, and Maurice W. Dysken
Journal of
the American Geriatrics Society. Volume 58 Issue
6, Pages 1027 - 1034
5
-
Duloxetine Versus Placebo in Patients With Chronic Low Back Pain: A
12-Week,
Fixed-Dose, Randomized, Double-Blind Trial
Vladimir Skljarevski, Shuyu Zhang, Durisala
Desaiah, Karla J. Alaka, Santiago
Palacios, Tomasz Miazgowski and Kyle
Patrick
The Journal
of Pain. Article in Press, May 2010
3
-
Established Donepezil Treatment Modulates Regional Brain Activation in
Early
Alzheimer's Disease
W.J. McGeown, M.F.
Shanks, K.E. Forbes-McKay,
G.D. Waiter, I. Elrick, M.G. Venneri, A. Venneri
Current
Alzheimer Research 2010; Volume 7 Issue 5: 415-427
3
- The
Serum
Protein and Lipid Oxidation Marker Levels in Alzheimer's Disease and
Effects of
Cholinesterase Inhibitors and Antipsychotic Drugs Therapy
F. Sinem, K. Dildar, E.
Gokhan, B. Melda, Y.
Orhan, M. Filiz
Current
Alzheimer Research 2010; Volume 7 Issue 5: 463-469
| Regresar a RESÚMENES MAYO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |